Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Protective Effects of Daratumumab on Carfilzomib-Related Cardiac Dysfunction in Patients with Relapsed Multiple Myeloma: Results from an Observational Study

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-137169

Published: 2020

Journal Articles

Clinical Impact of an Early Response and of Early Initiation of Salvage Therapy in Patients with Systemic Light Chain (AL) Amyloidosis

Eftathios Kastritis, Maria Gavriatopoulou, MD, Maria Roussou, MD, Magdalini Migkou, MD, Despina Fotiou, BMBS, MA, Ioanna Dialoupi, MD, Nikolaos Kanellias, MD, Evangelos Eleutherakis-Papaiakovou, MD, Foteini Theodorakakou, MD, Asimina Papanikolaou, MD, Erasmia Psimenou, MD, Kimon Stamatelopoulos, MD, Efstathios Manios, MD, Maria Irini Tselegkidi, MD, Argyrios Ntalianis, MD, Stavroula Giannouli, MD PhD, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 1894.

https://doi.org/10.1182/blood-2019-128208

Published: 2019

Journal Articles

Carfilzomib Induces Acute Endothelial Dysfunction Which Correlates with the Occurrence of Cardiovascular Events

Efstathios Kastritis, MD, Aggeliki Laina, MD, Maria Gavriatopoulou, MD, Georgios Georgiopoulos, MD, Evangelos Eleutherakis-Papaiakovou, MD, Fotiou Despina, MD, Nikolaos Kanellias, MD, Ioanna Dialoupi, MD, Nikolaos Makris, Efstathios Manios, MD, Magdalini Migkou, MD, Dimitrios C. Ziogas, MD, Maria Roussou, MD, Aristea-Maria Papanota, MD, Eleni-Dimitra Papanagnou, Evangelos Terpos, MD PhD, Ioannis P. Trougakos, Kimon Stamatelopoulos, MD, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 3247.

https://doi.org/10.1182/blood-2018-99-113792

Published: 2018

Journal Articles

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

Blood (2018) 132 (Supplement 1): 3248.

https://doi.org/10.1182/blood-2018-99-111608

Published: 2018

Journal Articles

Early Relapse Post Autologous Transplantation Is Associated with Very Poor Survival and Identifies an Ultra High Risk Group of Myeloma Patients

Efstathios Kastritis, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Magdalini Migkou, Dimitra Gika, Despina Fotiou, Nikolaos Kanellias, Dimitrios C. Ziogas, Ioannis Ntanasis-Stathopoulos, Despina Mparmparousi, Anastasia Gatou, Despina Katopi, Efstathios Manios, Michail Liontos, Stavroula Giannouli, Panagiotis Tsirigotis, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos

Blood (2017) 130 (Supplement 1): 3117.

https://doi.org/10.1182/blood.V130.Suppl_1.3117.3117

Published: 2017

Journal Articles

Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients with AL Amyloidosis Treated with Bortezomib

Efstathios Kastritis, MD, Maria Gavriatopoulou, Maria Roussou, Despina Fotiou, Dimitrios Ziogas, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Ioannis Panagiotidis, Erasmia Psimenou, Elektra Papadopoulou, Constantinos Pamboucas, Efstathios Manios, MD, Harikleia Gakiopoulou, MD, Anna Tasidou, MD, Stavroula Giannouli, Evangelos Terpos, MD PhD, Meletios A Dimopoulos

Blood (2016) 128 (22): 4500.

https://doi.org/10.1182/blood.V128.22.4500.4500

Published: 2016

Journal Articles

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Evangelos Repasos, Elektra Papadopoulou, Kimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis, MD

Blood (2016) 128 (22): 4491.

https://doi.org/10.1182/blood.V128.22.4491.4491

Published: 2016

Journal Articles

Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis

Efstathios Kastritis, Ioannis Papassotiriou, Evangelos Terpos, Maria Roussou, Maria Gavriatopoulou, Anna Komitopoulou, Chrysanthi Skevaki, Evangelos Eleutherakis-Papaiakovou, Constantinos Pamboucas, Erasmia Psimenou, Efstathios Manios, Stavroula Giannouli, Marianna Politou, Harikleia Gakiopoulou, Elektra Papadopoulou, Kimon Stamatelopoulos, Anna Tasidou, Meletios A. Dimopoulos

Blood (2016) 128 (3): 405–409.

https://doi.org/10.1182/blood-2016-02-702696

Published: 2016

Includes: Supplemental data

Journal Articles

Prospective Evaluation of Blood Pressure Monitoring and Baroreceptor Reflex Sensitivity (BRS) in Patients with AL Amyloidosis: Prognostic and Pathophysiologic Implications

Efstathios Kastritis, MD, Maria Roussou, Despoina Fotiou, Dimitrios Ziogas, Maria Gavriatopoulou, Kimon Stamatelopoulos, Constantinos Pamboucas, Elektra Papadopoulou, Fotios Michas, Aikaterini Lykka, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Manios

Blood (2015) 126 (23): 3054.

https://doi.org/10.1182/blood.V126.23.3054.3054

Published: 2015

Journal Articles

Low Circulating Mannan-Binding Leptin Levels Correlate with Increased Number of Febrile Episodes in Myeloma Patients Who Undergo High Dose Melphalan with Autologous Hematopoietic Stem Cell Transplantation and Do Not Receive Antibiotic Prophylaxis

Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Dimitrios Christoulas, Magdalini Migkou, Efstathios Kastritis, Maria Gkotzamanidou, Nikitas Nikitas, Efstathios Manios, Meletios Athanasios Dimopoulos, MD, Christos Papadimitriou

Blood (2011) 118 (21): 4457.

https://doi.org/10.1182/blood.V118.21.4457.4457

Published: 2011

Journal Articles

The Impact of Different Pre-Transplant Regimens Including Novel Agents On Peripheral Blood Mobilization, Harvest, Response and Survival in Patients Undergoing ASCT for Multiple Myeloma. A Single-Center Experience in 210 Patients.

Evangelos Eleutherakis-Papaiakovou, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Maria Roussou, Despina Mparmparoussi, Charis Matsouka, Efstathios Manios, Eleni Efstathiou, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, Christos Papadimitriou

Blood (2009) 114 (22): 2279.

https://doi.org/10.1182/blood.V114.22.2279.2279

Published: 2009

Journal Articles

Antibacterial Prophylaxis Reduces the Incidence of Neutropenic Fever and the Rate of Infections in Patients with Multiple Myeloma Who Undergo An Autologous Stem Cell Transplantation.

Evangelos Eleutherakis-Papaiakovou, Evangelos Kostis, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Maria Roussou, Despina Mparmparoussi, Charis Matsouka, Efstathios Manios, Eleni Efstathiou, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, Christos Papadimitriou

Blood (2009) 114 (22): 3334.

https://doi.org/10.1182/blood.V114.22.3334.3334

Published: 2009

Journal Articles

Consolidation Therapy with Bortezomib, Thalidomide and Dexamethasone (VTD) Regimen After ASCT in Myeloma Patients Who Do Not Receive Bisphosphonates Reduces Bone Resorption and RANKL/OPG Ratio but Seems to Have No Effect On Bone Formation and Angiogenesis.

Evangelos Terpos, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Athanasios Papatheodorou, Evangelos Eleutherakis-Papaiakovou, Efstathios Manios, Efstathios Kastritis, Christos Papadimitriou, Meletios A. Dimopoulos

Blood (2009) 114 (22): 3863.

https://doi.org/10.1182/blood.V114.22.3863.3863

Published: 2009

NARROW

Protective Effects of Daratumumab on Carfilzomib-Related Cardiac Dysfunction in Patients with Relapsed Multiple Myeloma: Results from an Observational Study

Clinical Impact of an Early Response and of Early Initiation of Salvage Therapy in Patients with Systemic Light Chain (AL) Amyloidosis

Carfilzomib Induces Acute Endothelial Dysfunction Which Correlates with the Occurrence of Cardiovascular Events

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

Early Relapse Post Autologous Transplantation Is Associated with Very Poor Survival and Identifies an Ultra High Risk Group of Myeloma Patients

Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients with AL Amyloidosis Treated with Bortezomib

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis

Prospective Evaluation of Blood Pressure Monitoring and Baroreceptor Reflex Sensitivity (BRS) in Patients with AL Amyloidosis: Prognostic and Pathophysiologic Implications

Low Circulating Mannan-Binding Leptin Levels Correlate with Increased Number of Febrile Episodes in Myeloma Patients Who Undergo High Dose Melphalan with Autologous Hematopoietic Stem Cell Transplantation and Do Not Receive Antibiotic Prophylaxis

The Impact of Different Pre-Transplant Regimens Including Novel Agents On Peripheral Blood Mobilization, Harvest, Response and Survival in Patients Undergoing ASCT for Multiple Myeloma. A Single-Center Experience in 210 Patients.

Antibacterial Prophylaxis Reduces the Incidence of Neutropenic Fever and the Rate of Infections in Patients with Multiple Myeloma Who Undergo An Autologous Stem Cell Transplantation.

Consolidation Therapy with Bortezomib, Thalidomide and Dexamethasone (VTD) Regimen After ASCT in Myeloma Patients Who Do Not Receive Bisphosphonates Reduces Bone Resorption and RANKL/OPG Ratio but Seems to Have No Effect On Bone Formation and Angiogenesis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only